about
A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancerVitamin D receptor genetic polymorphisms are associated with PSA level, Gleason score and prostate cancer risk in African-American men.1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells.Strategies for prostate cancer prevention: Review of the literature.1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells.1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells.
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Vitamin D and prostate cancer.
@ast
Vitamin D and prostate cancer.
@en
type
label
Vitamin D and prostate cancer.
@ast
Vitamin D and prostate cancer.
@en
prefLabel
Vitamin D and prostate cancer.
@ast
Vitamin D and prostate cancer.
@en
P1476
Vitamin D and prostate cancer.
@en
P2093
P356
10.1046/J.1525-1373.1999.D01-60.X
P577
1999-06-01T00:00:00Z